Filing Details

Accession Number:
0001209191-11-055029
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-08 18:00:40
Reporting Period:
2011-11-08
Filing Date:
2011-11-08
Accepted Time:
2011-11-08 18:00:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100962 Endo Pharmaceuticals Holdings Inc ENDP Pharmaceutical Preparations (2834) 134022871
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1034273 Michael Hyatt 383 Madison Avenue
43Rd Floor
New York NY 10179
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value, $0.01 Per Share Acquisiton 2011-11-08 5,000 $11.00 5,000 No 4 M Direct
Common Stock, Par Value, $0.01 Per Share Disposition 2011-11-08 5,000 $32.31 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 2000 Stock Incentive Plan Options Disposition 2011-11-08 5,000 $0.00 5,000 $11.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-03-12 No 4 M Direct
Footnotes
  1. This represents the average price that Mr. Hyatt's common shares were sold at on November 8, 2011.
  2. Mr. Hyatt's stock options that were granted under the 2000 Stock Incentive Plan on March 12, 2002 were exercisable 25% per year on each of March 12, 2003, March 12, 2004, March 12, 2005 and March 12, 2006. The 5,000 stock options that were exercised now represent all of the shares exercisable from Mr. Hyatt's original grant of 5,000 stock options.
  3. These securities were granted to Mr. Hyatt in consideration of his services on the Endo Pharmaceuticals Holdings Inc. Board of Directors.